RT Journal Article
SR Electronic
T1 Major outbreak of endophthalmitis after cataract surgery: a retrospective cohort in northern Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.08.23285557
DO 10.1101/2023.02.08.23285557
A1 Priscilla Perez da Silva Pereira
A1 Andriely Alayne Carvalho Sabini
A1 Rosa Maria Ferreira de Almeida
A1 Daniela Oliveira Pontes
A1 Márcia Maria Bezerra Mororó Alves
A1 Viviane Alves de Sousa
A1 Magzan da Silva Azevedo
A1 Adalgiza de Souza Botelho
A1 Surlange Freire Ramalhaes
A1 Edilson Batista da Silva
YR 2023
UL http://medrxiv.org/content/early/2023/02/10/2023.02.08.23285557.abstract
AB Background Endophthalmitis is one of the most important adverse events after cataract surgery as it can lead to total vision loss. The aim of this study was to describe the occurrence of endophthalmitis after phacoemulsification with intraocular lens implantation among patients assisted during a joint effort in Porto Velho, Rondônia, Brazil.Method This is a retrospective cohort study, carried out from a bank with 649 medical records of patients who underwent surgery. Descriptive analysis and multiple analysis using Robust Poisson Regression were performed to estimate relative risks (RR) and 95% confidence intervals (95%CI). A statistical analysis was performed using the statistical program Stata® version 16.0 (College Station, Texas, USA).Results The incidence of postoperative endophthalmitis confirmed by culture was 10.88%, the highest ever recorded in the world. A higher risk for endophthalmitis was found, in probable cases, among males (RR: 1.88; 95%CI:1.03; 3.44) and brown and yellow skin color (RR: 2.78; 95 %CI %: 1.17; 6.60). For confirmed and probable cases, bilateral surgery and specific lens model were also risk factors. The predominant etiological agents were gram-negative and the main clinical manifestation was corneal edema. The average number of days to start treatment was eight days and 27.12% used antibiotics.Conclusion Specific protocols are needed for cataract surgeries that encompass hiring, performing and monitoring these services to ensure good practices and patient safety.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is part of the matrix project entitled "Good Practices in Patient Care, Infection Control and Processing of Health Products in the State of Rondonia", authorized by the Ethics and Research Committee of the Federal University of Rondonia, Brazil, CAE 20070719.5.0000.5300.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.